文章：

肝细胞癌切除策略更新：一项叙述性综述

Update on Resection Strategies for Hepatocellular Carcinoma: A Narrative Review

原文发布日期：6 December 2024

DOI: 10.3390/cancers16234093

类型: Article

开放获取: 是

英文摘要：

Hepatocellular carcinoma (HCC) is the most common primary liver cancer, the incidence of which is rising globally. Despite recent advancements in immunotherapeutic and surgical treatment modalities, the prognosis for HCC remains poor. The surgical treatment strategy for HCC comprises a multimodal effort that ranges from ablative therapy and surgical resection to liver transplantation. Thanks to collective efforts from the surgical society, there have been rapid advances in resection strategies, such as 3D printing for surgical planning and minimally invasive techniques to minimize surgical trauma. This review examines recent advancements in surgical techniques, patient selection criteria, and perioperative management for HCC resection. The purpose of this review was to provide clinicians and researchers with an up-to-date perspective on the evolving role of surgical resection in HCC treatment, and to identify key areas for future investigation to improve patient outcomes.

摘要翻译： 

肝细胞癌（HCC）是最常见的原发性肝癌，其全球发病率正持续上升。尽管近年来免疫治疗与外科治疗手段有所进展，但HCC的预后仍然不佳。HCC的外科治疗策略涵盖多模式综合方案，包括消融治疗、手术切除乃至肝移植。得益于外科学界的共同努力，肝切除策略已取得显著进展，例如应用于手术规划的三维打印技术和旨在减少手术创伤的微创技术。本综述系统探讨了HCC切除术在手术技术、患者选择标准和围手术期管理方面的最新进展，旨在为临床医师和研究人员提供关于手术切除在HCC治疗中不断演变作用的最新视角，并指出未来改善患者预后的关键研究方向。

原文链接：

Update on Resection Strategies for Hepatocellular Carcinoma: A Narrative Review